BioLife Solutions Received Notice of Delisting
Alpha Vantage · TradingView · · AI-summarised by FinFlash
BioLife Solutions (BLFS) received a notice of delisting from Nasdaq. This action followed the completion of its merger with Repligen, which led the company to cease meeting Nasdaq listing requirements. Trading of BLFS stock was halted after-market on October 5, 2026, and suspended as of the close on October 6, 2026, with plans to officially delist and terminate reporting obligations by filing Forms 25 and 15.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.